Antibiotics

Catalog Product Name / CAS / Description Structure
BBF-04405

FD-838 (110341-78-1)

Inquiry

FD-838 is produced from the mycelia of the basidiomycete Hericium erinaceum. FD-838 inhibits the growth of two plant fungal pathogens Botrytis cinerea and Glomerella cingulata. It has anti-tumor activity.

BBF-04415

Quinupristin (120138-50-3)

Inquiry

Quinupristin is an antibiotic and usually used in combination with dalfopristin (The trade name is Synercid). It is active against Gram-positive bacteria through inhibiting protein synthesis of the cells, but not active against Gram-negative bacteria, so it needs to be given in combination with other antibacterials for mixed infections which also involve Gram-negative organisms.

BBF-04417

Virustomycin A (84777-85-5)

Inquiry

Virustomycin A is a 18-membered macrolide antibiotic originally isolated from Streptomyces sp. AM-2604. It is effective against infectious and plant pathogenic fungi. It is active against trichomonads and various RNA and DNA viruses.

BBF-04421

Cephradine monohydrate is the first generation cephalosporin, which is active against a wide range of Gram-positive and Gram-negative bacteria.

BBF-04424

Sultriecin (131774-59-9)

Inquiry

Sultriecin is a dominant analogue in the family of triene antibiotic isolated from Streptomyces. It is a phosphate ester of fostriecin and displays potent antifungal and antitumour activity.

BBF-04430

A semi-synthetic pleuromutilin formed by selective reduction of the ethene to ethyl. It exhibits comparable antibiotic potency to pleuromutilin.

BBF-04431

A secondary degradation product formed by dehydration of epichlortetracycline at the C6 position to aromatise the B ring. It is an important standard for monitoring tetracycline stability.

BBF-04432

Erythromycin C (1675-02-1)

Inquiry

A minor co-metabolite of erythromycin produced by saccharopolyspora erythreae. It exhibits a narrow spectrum of antibacterial activity, and it is much less active than erythromycin A and B.

BBF-04433

Gentamicin C1 (25876-10-2)

Inquiry

It is a broad-spectrum aminoglycoside antibiotic produced by the strain of Micromonospora spp. One of several components of the gentamicin C complex which comprises approximately 80% gentamicin and exhibits the most potent antimicrobial activity.

BBF-04434

Gentamicin C1a (26098-04-4)

Inquiry

It is a broad-spectrum aminoglycoside antibiotic produced by the strain of Micromonospora spp. One of several components of the gentamicin C complex which comprises approximately 80% gentamicin and exhibits the most potent antimicrobial activity.

BBF-04435

Gentamicin C2 (25876-11-3)

Inquiry

It is an aminoglycoside antibiotic produced by the strain of Micromonospora spp. One of several components of the gentamicin C complex which can comprise 25-55% gentamicin depending on the manufacturer or manufacturing process.

BBF-04441

A salt of the semi-synthetic tetracycline analogue, pirlimycin. It is a broad spectrum lincosaminide antibiotic with activity against anaerobic bacteria and protozoans by binding to the 23S ribosomal subunit, blocking protein synthesis. It is also an impurity of Clindamycin.

BBF-04443

The hydrochloride salt of a rare semi-synthetic tetracycline. It is prepared by hydrogenolysis of the chloro and benzylic hydroxy moieties of declomycin. It inhibits protein translation by reversibly binding to the 30S ribosomal subunit and blocking the entry of aminoacyl tRNA into the ribosomal A site. It is a semi-synthetic antibiotic with activity against tetracycline-resistant E. coli, S. aureus and E. faecalis.

BBF-04455

Citromycin (37209-30-6)

Inquiry

Citromycin, an antibiotic, is isolated from the cultures of two strains of Streptomyces.

BBF-04476

Gentamicin X2 (36889-17-5)

Inquiry

One of several different components found in standard grade Gentamicin. Gentamicin is an aminoglycoside antibiotic.

BBF-04479

17-AAG (75747-14-7)

Inquiry

17-AAG is an antibiotic with antineoplastic activity that inhibits heat shock protein 90 (HSP90). It was shown to induce apoptosis of mouse lymphoma cancer stem cells (CSCs) and human acute myeloid leukemia (AML) CSCs.

BBF-04481

A broad spectrum third generation cephalosporin targeting a wide range of gram-positive and gram-negative organisms. It is especially useful against pathogens responsible for causing ear, nose, and throat infections such as haemophilus influenzae and moraxella.

BBF-04486

Sulfapyridine (144-83-2)

Inquiry

Sulfapyridine is a short-acting sulfonamide antibiotic used in the treatment of dermatitis herpetiformis. It has antibacterial activity.

BBF-04488

JBIR-15 (1198588-57-6)

Inquiry

JBIR-15 is an aspochracin derivative metabolized from Aspergillus sclerotiorum. It exhibits antifungal activity against C. albicans.

BBF-04494

Neohydroxyaspergillic acid is an antibiotic produced by Aspergillus sckrotiorum, which is active against some bacteriophages and fungus.

cartIcon
Inquiry Basket